Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MBNL2 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MBNL2 mRNA | CTD | PMID:22079256 | MBNL2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MBNL2 mRNA | CTD | PMID:36331819 | MBNL2 | Human | 1,2-dichloroethane | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of MBNL2 mRNA | CTD | PMID:28960355 | MBNL2 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBNL2 mRNA | CTD | PMID:22206623 | MBNL2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MBNL2 mRNA | CTD | PMID:22206623 | MBNL2 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of MBNL2 mRNA | CTD | PMID:17108234 | MBNL2 | Human | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of MBNL2 mRNA | CTD | PMID:18936297 | MBNL2 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA | CTD | PMID:17942748 | MBNL2 | Human | 17beta-estradiol | affects expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of MBNL2 mRNA | CTD | PMID:32145629 | MBNL2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 | MBNL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBNL2 mRNA | CTD | PMID:17942748 | MBNL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MBNL2 mRNA | CTD | PMID:32109520 and PMID:34747641 | MBNL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MBNL2 mRNA | CTD | PMID:25270620 | MBNL2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MBNL2 mRNA | CTD | PMID:21570461 | MBNL2 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | MBNL2 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of MBNL2 mRNA | CTD | PMID:21179406 | MBNL2 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of MBNL2 mRNA | CTD | PMID:30951980 | MBNL2 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of MBNL2 gene | CTD | PMID:31683443 | MBNL2 | Human | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of MBNL2 gene | CTD | PMID:31601247 | MBNL2 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of MBNL2 mRNA | CTD | PMID:33297965 | MBNL2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of MBNL2 mRNA | CTD | PMID:30047161 | MBNL2 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of MBNL2 mRNA | CTD | PMID:32763439 | MBNL2 | Human | aflatoxin B1 | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of MBNL2 mRNA | CTD | PMID:19770486 | MBNL2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of MBNL2 gene | CTD | PMID:27153756 | MBNL2 | Human | aldrin | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Aldrin results in decreased expression of MBNL2 mRNA | CTD | PMID:18579281 | MBNL2 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MBNL2 mRNA | CTD | PMID:21934132 | MBNL2 | Human | all-trans-retinoic acid | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Tretinoin results in increased expression of MBNL2 mRNA | CTD | PMID:20488242 | MBNL2 | Human | amitrole | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of MBNL2 mRNA | CTD | PMID:30047161 | MBNL2 | Human | antimycin A | increases expression | EXP | | 6480464 | Antimycin A results in increased expression of MBNL2 mRNA | CTD | PMID:33512557 | MBNL2 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of MBNL2 mRNA | CTD | PMID:24449571 | MBNL2 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of MBNL2 mRNA | CTD | PMID:33212167 | MBNL2 | Human | Aroclor 1254 | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of MBNL2 mRNA | CTD | PMID:23650126 and PMID:25270620 | MBNL2 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA | CTD | PMID:32525701 | MBNL2 | Human | arsane | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of MBNL2 gene | CTD | PMID:31135185 | MBNL2 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA | CTD | PMID:32525701 | MBNL2 | Human | arsenic atom | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of MBNL2 gene | CTD | PMID:31135185 | MBNL2 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MBNL2 mRNA | CTD | PMID:22521957 | MBNL2 | Human | atrazine | affects methylation | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of MBNL2 gene | CTD | PMID:28931070 | MBNL2 | Human | atrazine | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of MBNL2 mRNA | CTD | PMID:36841081 | MBNL2 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MBNL2 mRNA | CTD | PMID:20064835 | MBNL2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of MBNL2 5' UTR and Benzo(a)pyrene affects the methylation of MBNL2 promoter | CTD | PMID:27901495 | MBNL2 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MBNL2 mRNA | CTD | PMID:26238291 | MBNL2 | Human | benzo[a]pyrene | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MBNL2 mRNA | CTD | PMID:22228805 | MBNL2 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | MBNL2 | Human | bisphenol A | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MBNL2 mRNA | CTD | PMID:25181051 and PMID:33296240 | MBNL2 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MBNL2 mRNA | CTD | PMID:36232920 | MBNL2 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBNL2 gene | CTD | PMID:31601247 | MBNL2 | Human | bisphenol A | affects expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of MBNL2 mRNA | CTD | PMID:32145629 | MBNL2 | Human | bisphenol A | increases methylation | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of MBNL2 promoter | CTD | PMID:27312807 | MBNL2 | Human | bisphenol A | increases methylation | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MBNL2 gene | CTD | PMID:28505145 | MBNL2 | Human | bisphenol A | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MBNL2 mRNA | CTD | PMID:21932408 and PMID:25594700 | MBNL2 | Human | bisphenol F | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of MBNL2 mRNA | CTD | PMID:30951980 | MBNL2 | Human | captan | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Captan results in increased expression of MBNL2 mRNA | CTD | PMID:31558096 | MBNL2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MBNL2 gene] | CTD | PMID:28238834 | MBNL2 | Human | ciguatoxin CTX1B | affects expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of MBNL2 mRNA | CTD | PMID:18353800 | MBNL2 | Human | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of MBNL2 mRNA | CTD | PMID:19691856 | MBNL2 | Human | copper atom | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of MBNL2 mRNA | CTD | PMID:30556269 | MBNL2 | Human | copper(0) | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of MBNL2 mRNA | CTD | PMID:30556269 | MBNL2 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of MBNL2 mRNA | CTD | PMID:19549813 | MBNL2 | Human | crocidolite asbestos | affects expression | EXP | | 6480464 | Asbestos and Crocidolite affects the expression of MBNL2 mRNA | CTD | PMID:25757056 | MBNL2 | Human | cyclosporin A | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of MBNL2 mRNA | CTD | PMID:19770486 | MBNL2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of MBNL2 mRNA | CTD | PMID:20106945 more ... | MBNL2 | Human | cyproconazole | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | cyproconazole results in increased expression of MBNL2 mRNA | CTD | PMID:22334560 | MBNL2 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MBNL2 mRNA | CTD | PMID:22521957 | MBNL2 | Human | dibutyl phthalate | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of MBNL2 mRNA | CTD | PMID:21266533 | MBNL2 | Human | dibutyl phthalate | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of MBNL2 mRNA | CTD | PMID:21266533 | MBNL2 | Human | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MBNL2 mRNA | CTD | PMID:20042640 | MBNL2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | MBNL2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MBNL2 mRNA | CTD | PMID:29803840 | MBNL2 | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of MBNL2 mRNA | CTD | PMID:26272509 | MBNL2 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MBNL2 mRNA | CTD | PMID:27188386 | MBNL2 | Human | epoxiconazole | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of MBNL2 mRNA | CTD | PMID:22334560 | MBNL2 | Human | epoxiconazole | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MBNL2 mRNA | CTD | PMID:35436446 | MBNL2 | Human | ethanol | affects splicing | ISO | Mbnl2 (Mus musculus) | 6480464 | Ethanol affects the splicing of MBNL2 mRNA | CTD | PMID:30319688 | MBNL2 | Human | ethanol | affects expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Ethanol affects the expression of MBNL2 mRNA | CTD | PMID:30319688 | MBNL2 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of MBNL2 mRNA | CTD | PMID:23649840 | MBNL2 | Human | folic acid | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MBNL2 mRNA | CTD | PMID:25629700 | MBNL2 | Human | folic acid | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBNL2 mRNA | CTD | PMID:22206623 | MBNL2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBNL2 gene | CTD | PMID:31601247 | MBNL2 | Human | geldanamycin | increases expression | EXP | | 6480464 | geldanamycin results in increased expression of MBNL2 mRNA | CTD | PMID:26705709 | MBNL2 | Human | gentamycin | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of MBNL2 mRNA | CTD | PMID:33387578 | MBNL2 | Human | glafenine | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Glafenine results in decreased expression of MBNL2 mRNA | CTD | PMID:24136188 | MBNL2 | Human | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of MBNL2 mRNA | CTD | PMID:25523186 | MBNL2 | Human | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of MBNL2 mRNA | CTD | PMID:25523186 | MBNL2 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of MBNL2 protein | CTD | PMID:32959892 | MBNL2 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of MBNL2 mRNA | CTD | PMID:28988120 | MBNL2 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MBNL2 mRNA | CTD | PMID:35811015 | MBNL2 | Human | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of MBNL2 mRNA | CTD | PMID:35811015 | MBNL2 | Human | Mesaconitine | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | mesaconitine results in increased expression of MBNL2 protein | CTD | PMID:37182599 | MBNL2 | Human | methapyrilene | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of MBNL2 mRNA | CTD | PMID:30467583 | MBNL2 | Human | methidathion | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | methidathion results in increased expression of MBNL2 mRNA | CTD | PMID:34813904 | MBNL2 | Human | methimazole | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of MBNL2 mRNA | CTD | PMID:30047161 | MBNL2 | Human | methoxychlor | affects methylation | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of MBNL2 gene | CTD | PMID:35440735 | MBNL2 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of MBNL2 mRNA | CTD | PMID:23649840 | MBNL2 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of MBNL2 mRNA | CTD | PMID:28001369 | MBNL2 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of MBNL2 mRNA | CTD | PMID:28001369 | MBNL2 | Human | methylseleninic acid | increases expression | EXP | | 6480464 | methylselenic acid results in increased expression of MBNL2 mRNA | CTD | PMID:18548127 | MBNL2 | Human | miconazole | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Miconazole results in decreased expression of MBNL2 mRNA | CTD | PMID:27462272 | MBNL2 | Human | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | increases expression | EXP | | 6480464 | N more ... | CTD | PMID:12756304 | MBNL2 | Human | nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of MBNL2 mRNA | CTD | PMID:17312168 | MBNL2 | Human | oxaliplatin | multiple interactions | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MBNL2 mRNA | CTD | PMID:25729387 | MBNL2 | Human | paracetamol | affects expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MBNL2 mRNA | CTD | PMID:17562736 | MBNL2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MBNL2 mRNA | CTD | PMID:21420995 | MBNL2 | Human | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of MBNL2 mRNA | CTD | PMID:32588087 | MBNL2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MBNL2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MBNL2 mRNA | CTD | PMID:36331819 | MBNL2 | Human | phenobarbital | affects expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of MBNL2 mRNA | CTD | PMID:23091169 | MBNL2 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of MBNL2 mRNA | CTD | PMID:26272509 | MBNL2 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA | CTD | PMID:27188386 | MBNL2 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MBNL2 mRNA | CTD | PMID:22079256 | MBNL2 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of MBNL2 mRNA | CTD | PMID:22079256 | MBNL2 | Human | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of MBNL2 mRNA | CTD | PMID:30047161 | MBNL2 | Human | propiconazole | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | propiconazole results in increased expression of MBNL2 mRNA | CTD | PMID:21278054 and PMID:22334560 | MBNL2 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MBNL2 mRNA | CTD | PMID:21632981 | MBNL2 | Human | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA | CTD | PMID:19059307 | MBNL2 | Human | rimonabant | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | Rimonabant inhibits the reaction [Dietary Fats results in increased expression of MBNL2 mRNA] | CTD | PMID:19030233 | MBNL2 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of MBNL2 mRNA | CTD | PMID:29955902 | MBNL2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MBNL2 mRNA | CTD | PMID:35811015 | MBNL2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | MBNL2 | Human | silver atom | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Silver results in decreased expression of MBNL2 mRNA | CTD | PMID:27131904 | MBNL2 | Human | silver(0) | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Silver results in decreased expression of MBNL2 mRNA | CTD | PMID:27131904 | MBNL2 | Human | sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MBNL2 mRNA] | CTD | PMID:21245298 | MBNL2 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MBNL2 mRNA | CTD | PMID:32525701 | MBNL2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MBNL2 mRNA | CTD | PMID:28595984 and PMID:34032870 | MBNL2 | Human | sodium dichromate | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of MBNL2 mRNA | CTD | PMID:31558096 | MBNL2 | Human | succimer | multiple interactions | ISO | Mbnl2 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MBNL2 mRNA | CTD | PMID:26378955 | MBNL2 | Human | sulfadimethoxine | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of MBNL2 mRNA | CTD | PMID:30047161 | MBNL2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of MBNL2 mRNA | CTD | PMID:31533062 | MBNL2 | Human | tacrolimus hydrate | decreases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Tacrolimus results in decreased expression of MBNL2 mRNA | CTD | PMID:25270620 | MBNL2 | Human | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MBNL2 mRNA | CTD | PMID:19059307 | MBNL2 | Human | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA | CTD | PMID:15336504 | MBNL2 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of MBNL2 mRNA | CTD | PMID:17440010 | MBNL2 | Human | tetrachloromethane | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of MBNL2 mRNA | CTD | PMID:27339419 and PMID:31919559 | MBNL2 | Human | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of MBNL2 mRNA | CTD | PMID:29453283 | MBNL2 | Human | thapsigargin | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Thapsigargin results in decreased expression of MBNL2 protein | CTD | PMID:35544339 | MBNL2 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of MBNL2 mRNA | CTD | PMID:27188386 | MBNL2 | Human | thioacetamide | decreases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of MBNL2 mRNA | CTD | PMID:34492290 | MBNL2 | Human | topotecan | multiple interactions | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MBNL2 mRNA | CTD | PMID:25729387 | MBNL2 | Human | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of MBNL2 mRNA | CTD | PMID:23228038 | MBNL2 | Human | trichloroethene | increases methylation | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of MBNL2 gene | CTD | PMID:27618143 | MBNL2 | Human | trichloroethene | increases expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of MBNL2 mRNA | CTD | PMID:33387578 | MBNL2 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of MBNL2 mRNA | CTD | PMID:24935251 and PMID:26272509 | MBNL2 | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of MBNL2 mRNA | CTD | PMID:28542535 | MBNL2 | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA | CTD | PMID:27188386 | MBNL2 | Human | troglitazone | increases expression | ISO | Mbnl2 (Mus musculus) | 6480464 | troglitazone results in increased expression of MBNL2 mRNA | CTD | PMID:28973697 | MBNL2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of MBNL2 mRNA | CTD | PMID:28818685 | MBNL2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MBNL2 mRNA | CTD | PMID:24935251 and PMID:26272509 | MBNL2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MBNL2 mRNA | CTD | PMID:28001369 | MBNL2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBNL2 mRNA | CTD | PMID:27188386 | MBNL2 | Human | vinclozolin | affects expression | ISO | Mbnl2 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of MBNL2 mRNA | CTD | PMID:19015723 | MBNL2 | Human | zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of MBNL2 mRNA | CTD | PMID:12756304 | |